HIPRA dedicates 10% of its annual turnover to R&D activities that concentrate on the creation and application of the latest scientific advances to the development of the highest quality innovative vaccines. To give added value to its vaccination experience, we also develop medical devices and traceability services.
Research & Innovation
Global leaders
HIPRA is the company that has launched the most biotech vaccines in the last 10 years, with a total of 22 vaccines. We are ranked as one of the global leaders in the veterinary industry developing vaccines for Animal Health.
World-class biotech
HIPRA works with biotechnology to create innovative solutions that meet the needs of animal health and now also human health.